BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 23, 2010
View Archived Issues
Second hESC Trial Clears FDA; ACT Set to Start Phase I/II Study
Read More
Stock Movers
Read More
Clinic Roundup
Read More
Financings Roundup
Read More
Other News To Note
Read More
Regeneron Stock Up 19.7% After Positive VEGF Trap-Eye Report
The talk from Regeneron Pharmaceuticals Inc. is of trials – clinical and, perhaps, legal. (BioWorld Today)
Read More
BI Hails F-Star's Fcab Platform in Seven-Target Antibody Deal
Read More